Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Horwitz

Showing results (51-60 of 192) with videos related to

Pageof 20
Sort By:
Urology|February 19, 2008
Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?David J D'Ambrosio, Karen Ruth, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Does treatment duration affect outcome after radiotherapy for prostate cancer?David J D'Ambrosio, Tianyu Li, Eric M Horwitz, et al.
Cancer|May 24, 2007
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapyPeter B Morgan, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraintsAwad A Ahmed, Brian Egleston, Pino Alcantara, et al.
Annals of Internal Medicine|March 29, 2020
A War on Two Fronts: Cancer Care in the Time of COVID-19Alexander Kutikov, David S Weinberg, Martin J Edelman, et al.
Journal of the National Cancer Institute|April 5, 2017
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate CancerAlan Pollack, Deukwoo Kwon, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046Mark K Buyyounouski, Alexandra L Hanlon, Robert A Price, et al.
The Journal of Urology|February 10, 2004
Prostate cancer radiotherapy dose response: an update of the fox chase experienceAlan Pollack, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
What dose of external-beam radiation is high enough for prostate cancer?Thomas N Eade, Alexandra L Hanlon, Eric M Horwitz, et al.
The Journal of Urology|May 29, 2003
Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy aloneEric M Horwitz, Robert G Uzzo, Alexandra L Hanlon, et al.
Pageof 20

Showing results (51-60 of 192) with videos related to

Sort By:
Pageof 20
Urology|February 19, 2008
Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?David J D'Ambrosio, Karen Ruth, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Does treatment duration affect outcome after radiotherapy for prostate cancer?David J D'Ambrosio, Tianyu Li, Eric M Horwitz, et al.
Cancer|May 24, 2007
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapyPeter B Morgan, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraintsAwad A Ahmed, Brian Egleston, Pino Alcantara, et al.
Annals of Internal Medicine|March 29, 2020
A War on Two Fronts: Cancer Care in the Time of COVID-19Alexander Kutikov, David S Weinberg, Martin J Edelman, et al.
Journal of the National Cancer Institute|April 5, 2017
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate CancerAlan Pollack, Deukwoo Kwon, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046Mark K Buyyounouski, Alexandra L Hanlon, Robert A Price, et al.
The Journal of Urology|February 10, 2004
Prostate cancer radiotherapy dose response: an update of the fox chase experienceAlan Pollack, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
What dose of external-beam radiation is high enough for prostate cancer?Thomas N Eade, Alexandra L Hanlon, Eric M Horwitz, et al.
The Journal of Urology|May 29, 2003
Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy aloneEric M Horwitz, Robert G Uzzo, Alexandra L Hanlon, et al.
Pageof 20